PER percheron therapeutics limited

Ann: Webinar Presentation - Phase IIb study of avicursen, page-27

  1. 4,275 Posts.
    lightbulb Created with Sketch. 2046
    Ryn i wrote the above because i get sick of the lack of accountability
    These people make mistakes SH are the ones that suffer and they carry on unaccountable for anything

    You know the arguments we had over the word of voight v my opinion on MRI

    To this day i believe i am correct and its not BS MRI if set up in the trial accordingly it can be used as a biomarker and used as a secondary endpoint

    Unless Italfarmalco and uhf are just writing BS and the FDA had taken no notice of their MRI

    But that is just not the case as we know and i have previously shown


    So i will ask you as it appears not to many are interested now or have moved on

    Do you believe the explanation that Cathryn gave in that webinar was the reason MRI was not included in our trial
    Or do you believe like me it was nothing more than a feeble cop out for not including it in the trial and hope it would be silently unnoticed
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.0¢
Change
0.000(0.00%)
Mkt cap ! $10.87M
Open High Low Value Volume
1.0¢ 1.0¢ 1.0¢ $71.80K 7.180M

Buyers (Bids)

No. Vol. Price($)
1 4649246 1.0¢
 

Sellers (Offers)

Price($) Vol. No.
1.1¢ 2600000 2
View Market Depth
Last trade - 15.21pm 13/06/2025 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.